Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
Clinical trial NCT00877773 · TERMINATED
Trial details
- NCT number
- NCT00877773
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2014-06-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.